Orca Bio is preparing to make a splash in the cell therapy market. The biotech has hired Steve Gavel as chief commercial officer, securing itself a leader with cell therapy expertise accrued at ...

New gene therapy improves the life of 18-year-old with Sickle Cell Disease which affects 5,000 New Jersey residents living with the condition. Skip to Article Set weather ...

A dual-target CAR T-cell therapy approach shows promise for slowing tumor growth in a notoriously aggressive and fast-growing brain cancer. Tumors became smaller after the experimental CAR T-cell ...

Explore the future of healthcare with our in-depth report on NK cell therapies. Anticipate the first NK cell therapy approval by 2028, with over 180 therapies in trials. Discover global trends ...

CAR-T cell therapy for hematologic cancers is now available at St. George Regional Hospital. Jacqueline, a Las Vegas patient who traveled to Salt Lake City for the treatment, said it saved her life.

Stem cell therapy is an emerging treatment for type 2 diabetes. Although it’s not yet FDA-approved in the United States, it is a rapidly expanding and promising field of research.

A next-generation "armored" CAR T cell therapy showed promising results in a small study of patients whose B-cell lymphomas continued to resist multiple rounds of other cancer treatments ...

While CAR T cell therapy -- a personalized form of cancer immunotherapy first successfully developed by Carl June, MD, and his team at Penn -- has revolutionized treatment for many blood cancers ...

Over the last 15 years, I have witnessed how cell and gene therapy (CGT) has evolved in many ways, spanning from research and development to manufacturing. Breakthroughs such as CAR-T and gene ...

The cell therapy has been well-tolerated at both dose levels, with no adverse events attributed to NRTX-1001 to date, according to Neurona. The biotech plans to launch other trials for NRTX-1001 ...

STAT Plus: Off-the-shelf stem cell therapy for type 1 diabetes continues to show positive results By Elizabeth Cooney. Health. Health June 20, 2025.

The therapy is being developed for B-cell-mediated autoimmune diseases and malignancies. Another of Century’s candidates is CNTY-341, a CD19/CD22 dual-targeted CAR-iT cell therapy.